田辺三菱製薬 臨床試験情報サイト
を離れます。よろしいですか?
(別ウィンドウが開きます)
We are leaving the Mitsubishi Tanabe Pharma Clinical Trial Information Site.
(A new window will be opened.)
Mitsubishi Tanabe Pharma Clinical Trial Information Site
The clinical trial information and results posted on ClinicalTrials.gov or CTIS of public registries are available after performing a search in the following.
The studies listed in the “Summary Results” and “Summary Results in Plain Language “ in the “List of Summaries of Clinical Trial Information” are clinical trials of a product which the first indication was approved in or after January 2018 in patients who applied for approval of marketing approved in all regions of the US, Europe, and Japan where approval is sought.
However, the results will not be disclosed if MTPC determines that there is a risk that the clinical trial participants could be identified. The results may not be disclosed in the following conditions:
Disease Area |
Development Code (Generic Name) |
Clinical Trial No. | Medical Indication or Disease |
Phase | Status of Clinical Trial |
ID ClinicalTrials.gov |
Summary of Clinical Trial |
Summary Results |
Summary Results in Plain Language |
---|---|---|---|---|---|---|---|---|---|
{{item.clinical_trial_no}} |
Phase {{n}} |
{{item.jrct}} {{item.clinical_trials_gov}} {{item.ctis}} |
Summary |
For questions regarding disclosure of clinical trial information, please email us: